Reports

ExxonMobil delivered $7.1 billion in net income and $1.64 EPS in Q2 2025, supported by record upstream production and growing sales of high-value products, offsetting margin pressures and lower energy prices.

• Reported net income of $7.1 billion and EPS of $1.64
• Cash flow from operations totaled $11.55 billion

Chevron delivered solid operational execution in Q2 2025, achieving record oil-equivalent production, particularly in the Permian Basin. However, earnings declined year-over-year due to lower oil prices and a fair value adjustment related to Hess shares.

• Net income was $2.49 billion, down from $4.43 billion in Q2 2024
• Adjusted earnings were $3.1 billion, excluding special items and FX effects

Linde delivered a robust Q2 2025 performance with increased revenue and net income. Operating margin remained high at 30.1%, and operating cash flow reached $2.2 billion, supported by pricing power and productivity gains.

• Revenue grew to $8.495 billion in Q2 2025.
• Diluted EPS reached $4.09, with adjusted EPS matching reported EPS.

Enbridge delivered solid Q2 2025 results with adjusted EBITDA reaching C$4.644 billion and net income at C$2.2 billion, primarily due to strong gas transmission and gas distribution performance.

• Adjusted EBITDA reached a record C$4.644 billion for the quarter.
• Net income attributable to common shareholders was C$2.2 billion.

Colgate-Palmolive posted a 1.0% increase in net sales and continued leadership in oral care with strong global market share in both toothpaste and toothbrushes. Net income rose slightly, and adjusted EPS was up marginally. Organic sales grew despite headwinds in pet nutrition from lower private label sales.

• Net sales reached $5.11 billion, up from $5.058 billion the prior year.
• Organic sales increased 1.8%, despite weakness in private label pet food.

EOG Resources faced a challenging Q2 2025 with declines in revenue, net income, and operating income compared to the previous year. Despite the softness, the company maintained strong free cash flow and returned significant capital to shareholders.

• Q2 2025 revenue reached $5.05 billion, down from $5.57 billion in Q2 2024.
• GAAP EPS was $2.05; non-GAAP EPS was $2.21.

Regeneron Pharmaceuticals, Inc. delivered a strong second quarter in 2025, with total revenues increasing by 4% to $3.68 billion and non-GAAP EPS growing by 12% to $12.89. The company saw significant sales growth in EYLEA HD and Dupixent, achieved multiple FDA approvals for key products, and made substantial progress in its oncology and other therapeutic pipelines.

• Total revenues for Q2 2025 increased by 4% year-over-year, reaching $3.676 billion.
• Non-GAAP diluted EPS rose by 12% to $12.89, while GAAP diluted EPS increased by 3% to $12.81.

Grainger reported revenue growth driven by strong performance in its Endless Assortment segment, although operating and gross margins declined slightly due to tariff-related pressures.

• Revenue reached $4.554 billion, up 5.6% from Q2 2024
• Adjusted EPS rose to $9.97, up from $9.76 in Q2 2024

Dominion Energy delivered higher earnings in Q2 2025, driven by strong performance in its Virginia and South Carolina segments. Revenue and net income both rose compared to the same period last year, with continued affirmation of full-year guidance.

• GAAP net income rose to $760M, up from $563M in Q2 2024
• Revenue increased to $3.81B, compared to $3.49B last year

The company posted robust organic growth and maintained profitability despite pricing pressures and currency impacts. Adjusted EPS slightly declined year-over-year, but strong operational execution contributed to high margins and improved cash returns.

• Organic net sales grew 3.9% driven by 5.0% volume growth
• Adjusted EPS was $1.92, down 2.0% from last year

Imperial Oil saw reduced earnings and revenue in Q2 2025 due to lower commodity prices and downstream margins. However, the company recorded its highest second-quarter upstream production in over 30 years and successfully completed major turnaround projects.

• Net income for Q2 2025 was CAD 949 million, down from CAD 1.13 billion in Q2 2024
• EPS was CAD 1.86, reflecting reduced upstream realizations and margin capture

Ares Management Corporation reported solid results for Q2 2025, highlighted by record gross capital raised, growth in assets under management, and increased fee-related earnings. The quarter marked the first full contribution from the GCP International acquisition.

• Generated GAAP net income of $137.1 million with EPS of $0.46
• Achieved record gross capital raised of $26.2 billion

Fortis Inc. delivered robust results in Q2 2025, with significant growth in earnings driven by rate base expansions and strategic capital projects, offset partially by higher operating costs and finance expenses.

• Net earnings increased to $384 million, up from $331 million in Q2 2024.
• Capital expenditures remained strong at $2.9 billion in the first half of 2025, aligning with the $5.2 billion annual plan.

Pembina Pipeline delivered Q2 2025 results marked by stable earnings, continued progress on capital projects, and strong operational performance, despite a modest decline in revenue.

• Q2 revenue totaled CAD 2.29B, slightly down from Q2 2024
• Adjusted EBITDA remained strong at CAD 935M

T. Rowe Price reported solid financial results in Q2 2025, with EPS increasing to $2.24 on revenues of $1.72 billion. Although total net outflows reached $14.9 billion, primarily from U.S. equities, fixed income and alternative strategies saw positive inflows. Operating expenses increased, impacting operating income margins slightly.

• EPS rose to $2.24, driven by stable revenue performance.
• Net revenues slightly decreased to $1.72 billion, influenced by lower advisory fees.

LyondellBasell posted $115 million in net income and $0.34 EPS in Q2 2025, down significantly from the prior year. Adjusted results were better, driven by strength in polyethylene and disciplined capital allocation. Revenues fell year over year, reflecting ongoing macroeconomic challenges.

• Reported net income of $115 million and EPS of $0.34
• Adjusted EPS came in at $0.62, excluding $87 million in identified items

Franklin Resources faced a challenging Q3 FY25 with declines in revenue and net income, although adjusted earnings remained relatively stable. The firm saw strong performance in alternative fundraising and ETF inflows, alongside improvements in institutional mandate activity.

• Net income dropped to $92.3M, down from $174M a year ago.
• Adjusted EPS was $0.49, while GAAP EPS fell to $0.15.

In Q2 2025, Suzano achieved growth in net revenue and adjusted EBITDA, driven by higher pulp and paper sales volumes and improved pricing. Net income rose compared to the prior year despite higher financial expenses. The company maintained solid cash generation and advanced its strategic investment projects.

• Net revenue reached R$ 12.03 billion, up from R$ 11.29 billion in Q2 2024.
• Adjusted EBITDA rose to R$ 7.21 billion with a margin of 60%.

Magna International delivered solid Q2 results, with EPS and net income rising year-over-year due to operational efficiency and disciplined cost control, despite a 3% drop in revenue.

• Revenue declined 3% year-over-year to $10.63 billion due to lower light vehicle production.
• Adjusted EBIT margin improved to 5.5%, driven by operational improvements.

DaVita exceeded earnings expectations in Q2 2025, driven by strong operating performance in U.S. dialysis and growth in international operations, while managing the financial impact of a cybersecurity event.

• Revenue reached $3.38 billion in Q2 2025, up from $3.11 billion in Q2 2024.
• GAAP EPS was $2.58; Adjusted EPS excluding one-time items was $2.95.

Moderna's Q2 2025 results reflected a continued downturn in COVID-19 vaccine sales, leading to a 41% drop in revenue. Despite the decline, the company reduced its net loss compared to last year and achieved cost savings in R&D and SG&A. Multiple new FDA approvals and pipeline progress are expected to drive future performance.

• Revenue fell to $142 million, down 41% year-over-year due to lower COVID-19 vaccine sales.
• Net loss narrowed to $800 million from $1.3 billion in Q2 2024.

KT delivered outstanding performance in Q2 2025, achieving operating income of KRW 1.01T and net income of KRW 733.3B. Revenue grew 13.5% YoY supported by gains in real estate, telecom, and digital services.

• Revenue reached KRW 7,427.4B, up 13.5% YoY.
• Operating income surged to KRW 1,014.8B, up 105.4% YoY.

Avantor's second quarter 2025 performance showed a slight decrease in net sales, reaching $1.68 billion, though organic revenue remained flat. Net income fell to $64.7 million, and adjusted EPS was $0.24. The Laboratory Solutions segment experienced a reported decrease in sales, while Bioscience Production saw an increase. The company generated strong operating cash flow of $154.4 million and free cash flow of $125.4 million.

• Net sales for Q2 2025 were $1.68 billion, a 1% decrease year-over-year, with organic revenue remaining flat.
• Net income for the quarter was $64.7 million, a decrease from $92.9 million in Q2 2024, and adjusted net income was $161.2 million.

Ingredion reported a solid second quarter with increased reported operating income and EPS, driven by strong performance in Texture & Healthful Solutions. Despite challenges in other segments like Food & Industrial Ingredients—LATAM and U.S./Canada, the company improved its full-year outlook, reflecting the resilience of its diversified business model.

• Second quarter 2025 reported EPS increased by 35% to $2.99, while adjusted EPS remained flat at $2.87 compared to the prior year.
• Reported operating income grew by 13% to $271 million, and adjusted operating income increased by 1% to $273 million.

Fluor's second quarter 2025 results were mixed, with a 6% year-over-year decrease in revenue to $4.0 billion. GAAP net earnings attributable to Fluor surged to $2.5 billion, primarily driven by a $3.2 billion pre-tax mark-to-market gain on its NuScale investment. However, adjusted EPS fell by 49% to $0.43, and adjusted EBITDA decreased by 42% to $96 million, reflecting cost growth on infrastructure projects and a shift in client capital spending. New awards were down significantly, and backlog also decreased.

• Revenue for Q2 2025 was $4.0 billion, a 6% decrease compared to the same period last year.
• GAAP net earnings attributable to Fluor reached $2.5 billion, largely due to a $3.2 billion pre-tax mark-to-market gain from the NuScale investment.

For Q2 2025, EchoStar delivered total revenue of 3724959000 and reported a net loss attributable to EchoStar of 306132000, with diluted EPS of -1.06. Wireless segment added 212000 net subscribers, while Pay-TV and Broadband saw declines in subscribers and revenues.

• Total revenue was 3724959000 in Q2 2025, down year-over-year. :contentReference[oaicite:0]{index=0}
• Net loss attributable to EchoStar was 306132000 with diluted EPS of -1.06. :contentReference[oaicite:1]{index=1}

NuScale Power generated $8.1M in revenue in Q2 2025, primarily from engineering and licensing services tied to the RoPower project. The company posted a net loss, reported adjusted EPS of -$0.13, and ended the quarter with $489.9M in liquidity.

• Q2 2025 revenue was $8.1M, mainly from RoPower project engineering and licensing fees.
• Adjusted EPS for the quarter was -$0.13.

Dun & Bradstreet reported Q2 2025 revenue of $564.3 million and net income of $6.2 million. While adjusted EBITDA remained strong, EPS declined from the prior year, and free cash flow was slightly negative.

• Revenue was flat YoY at $564.3 million, with modest organic growth of 0.3%.
• Adjusted EBITDA grew slightly to $231.8 million with a margin of 41.1%.

Cinemark posted its highest-ever quarterly domestic revenue, supported by strong concession performance and operational execution, achieving $941 million in total revenue and $95 million in net income.

• Total revenue reached $941 million, the highest quarterly domestic revenue ever recorded by Cinemark.
• Net income came in at $95 million, while adjusted EBITDA reached $232 million with a 24.7% margin.

Liberty Global posted a net loss of $2.77 billion for Q2 2025 despite revenue of $1.27 billion. Adjusted EBITDA rose 12.7% YoY. Telenet and VM Ireland contributed positively, while losses from Liberty Services & Corporate and Liberty Growth impacted bottom-line performance.

• Total revenue for Q2 2025 was $1.27 billion, up from $1.06 billion a year earlier.
• Reported net loss of $2.77 billion, driven largely by Liberty Services & Corporate segment losses.

Avient delivered solid Q2 2025 results, posting year-over-year growth in revenue and earnings. Net income rose significantly, with adjusted EPS slightly exceeding guidance. The company saw margin expansion and strong cash generation, which supported debt reduction efforts.

• Revenue grew to $866.5M, up from $849.7M in Q2 2024.
• Adjusted EPS came in at $0.80, exceeding the prior guidance of $0.79.

Crescent Energy exceeded expectations in Q2 2025, achieving high production and free cash flow while maintaining capital efficiency and strengthening its balance sheet.

• Generated $513,854,000 in Adjusted EBITDAX and $170,875,000 in Levered Free Cash Flow:contentReference[oaicite:0]{index=0}
• Achieved net income of $162,498,000 for the quarter:contentReference[oaicite:1]{index=1}

Newell Brands delivered second quarter 2025 financial results within its guidance ranges, with net sales of $1.9 billion and diluted EPS of $0.11. The company achieved its eighth consecutive quarter of gross margin expansion, reaching 35.4%, and improved its operating margin to 8.8%. Normalized net income was $101 million, and normalized diluted EPS was $0.24.

• Net sales for Q2 2025 were $1.9 billion, a 4.8% decline compared to the prior year period, with core sales declining 4.4%.
• Gross margin increased to 35.4% in Q2 2025, marking the eighth consecutive quarter of 100+ basis points expansion year-over-year.

Insperity experienced a challenging Q2 2025, reporting a net loss of $5 million despite 3% revenue growth to $1.658 billion. The company saw a 1% increase in average worksite employees paid and adjusted EPS of $0.26. Rising healthcare costs pressured margins, leading to a 14% drop in gross profit.

• Revenue increased 3% year-over-year to $1.658 billion.
• Reported net loss of $5 million and EPS of $(0.14), with adjusted EPS at $0.26.

In Q2 2025, NextDecade continued Phase 1 construction at the Rio Grande LNG Facility, completed commercialization of Train 4, signed key LNG agreements for Trains 4 and 5, and initiated financing processes to support upcoming FIDs.

• Trains 1 and 2 and common facilities reached 48.3% completion; Train 3 reached 22.7%
• Train 4 fully commercialized with 4.6 MTPA in SPAs and EPC pricing finalized

Patria delivered a solid second quarter in 2025, with fundraising reaching $1.3 billion and Fee Related Earnings (FRE) growing 17% year-over-year to $46.1 million. The company also saw significant growth in Fee Earning Assets Under Management (FEAUM) and generated over $600 million in organic net inflows, leading to an annualized organic growth rate exceeding 8% for the first half of the year. Despite potential macroeconomic headwinds, Patria is confident in achieving its full-year FRE target.

• Fundraising reached $1.3 billion in Q2 2025, contributing to $4.5 billion in the first half of the year.
• Fee Related Earnings (FRE) increased by 17% year-over-year to $46.1 million, with an FRE margin of 56.8%.

Arbor Realty Trust posted a solid quarter with positive net income and strong progress in financing activities, including a major securitization deal and a debt refinancing effort.

• Reported GAAP net income of $24.0 million and adjusted EPS of $0.25.
• Closed $801.9 million build-to-rent securitization, boosting balance sheet flexibility.

Xenia Hotels & Resorts delivered a robust second quarter in 2025, exceeding expectations with substantial growth across key financial and operational metrics. Net income attributable to common stockholders surged by 259.6% to $55.2 million, while Adjusted EBITDAre increased by 16.3% to $79.5 million. The company's Same-Property RevPAR rose by 4.0%, primarily due to strong performance at the Grand Hyatt Scottsdale Resort and significant increases in highly-profitable catering revenues.

• Net income attributable to common stockholders increased by 259.6% to $55.2 million, or $0.56 per share, significantly outperforming the prior year.
• Adjusted EBITDAre grew by 16.3% to $79.5 million, and Adjusted FFO per diluted share increased by 9.6% to $0.57.

Interface delivered strong second quarter 2025 results, with net sales totaling $376 million, an 8% increase year-over-year. The company saw significant profitability expansion, with GAAP EPS increasing by 45% to $0.55 and Adjusted EPS rising by 50% to $0.60. This performance was attributed to the 'One Interface' strategy, which fueled growth across all product categories and key market segments, particularly in the Americas.

• Net sales reached $376 million, an 8% increase year-over-year, and 7% currency neutral.
• GAAP earnings per diluted share increased by 45% to $0.55, while Adjusted earnings per diluted share rose by 50% to $0.60.

Perella Weinberg Partners experienced a challenging second quarter in 2025 with revenues significantly down by 43% year-over-year to $155.3 million, primarily due to decreased M&A activity. Despite the revenue decline, the firm returned to a GAAP operating income of $8.9 million and reported GAAP diluted EPS of $0.04, alongside an adjusted EPS of $0.09. The company also announced the strategic acquisition of Devon Park Advisors to expand its private funds advisory business.

• Revenues for Q2 2025 were $155.3 million, a 43% decrease from $272.0 million in Q2 2024, mainly due to lower M&A contribution.
• The firm reported GAAP diluted EPS of $0.04 and Adjusted EPS of $0.09 for the second quarter.

Dorian LPG experienced a challenging first quarter of fiscal year 2026, with revenues decreasing by 26.4% to $84.2 million and net income plummeting by 80.3% to $10.1 million compared to the prior year. The decline was largely driven by lower Time Charter Equivalent (TCE) rates and an increased number of vessels undergoing drydocking, impacting available days. Despite these headwinds, the company declared an irregular cash dividend of $0.60 per share, returning approximately $25.6 million to shareholders.

• Revenues for Q1 FY2026 were $84.2 million, a 26.4% decrease from $114.3 million in the same period last year.
• Net income significantly dropped to $10.1 million, or $0.24 EPS, compared to $51.3 million, or $1.25 EPS, in Q1 FY2025.

MFA Financial generated GAAP net income available to common stockholders of 22424000 in Q2 2025, or 0.22 per basic common share. Net interest income was 57503000 for the quarter. Economic book value per common share was 13.69, reflecting continued portfolio stability.

• GAAP net income available to common stockholders was 22424000.
• Basic EPS was 0.22 and distributable earnings per share was 0.24.

Insperity posted a net loss for Q2 2025 due to rising healthcare and benefits costs, which outweighed a slight increase in revenue and paid worksite employees.

• Q2 revenue increased 3% year-over-year to $1.658 billion
• Net loss of $5 million for the quarter

AdvanSix delivered resilient sequential improvement in Q2 2025, but faced continued softness in nylon and chemical intermediates. Strong performance in Plant Nutrients helped partially offset these pressures. Net income was down year-over-year, and the company reported negative free cash flow due to reduced operating cash flow and sustained capital investment.

• Revenue fell to $410 million, down 10% YoY due to lower nylon and chemical intermediates demand.
• EPS was $1.15, with adjusted EPS of $1.24 including $8 million in 45Q carbon capture tax credits.

Fulgent Genetics reported a total revenue of $81.8 million for the second quarter of 2025, with core revenue growing 16% year-over-year to $81.7 million. The company experienced a GAAP net loss of $19.0 million, or ($0.62) per share, which included a one-time charge. Non-GAAP income was $2.1 million, or $0.07 per share. The company ended the quarter with $777.5 million in cash, cash equivalents, restricted cash, and investments in marketable securities.

• Total revenue for Q2 2025 was $81.8 million.
• Core Revenue increased by 16% year-over-year, reaching $81.7 million.

The Marcus Corporation delivered a strong second quarter in fiscal 2025, with total revenues increasing by 17.0% to $206.0 million. Operating income significantly improved to $13.0 million from $2.2 million in the prior year, and the company reported net earnings of $7.3 million, a substantial turnaround from a net loss of $20.2 million in the same period last year. This growth was largely fueled by Marcus Theatres, which saw a 29.8% increase in revenues due to a strong film slate and increased attendance.

• Total revenues for Q2 fiscal 2025 increased by 17.0% to $206.0 million, up from $176.0 million in Q2 fiscal 2024.
• Operating income surged to $13.0 million in Q2 fiscal 2025, a significant improvement from $2.2 million in the prior year quarter.

Butterfly Network delivered its strongest revenue quarter ever at $23.4 million, marking a 9% year-over-year growth. The company also achieved record gross margins of 64% and significantly reduced its cash usage to $7.1 million, the lowest in any quarter, demonstrating strong financial discipline and progress towards breakeven.

• Achieved highest quarterly revenue in company history at $23.4 million, representing 9% year-over-year growth.
• Reached record gross margins of 64%, up from 58.6% in the prior year period, primarily due to higher average selling prices and improved software and services margins.

Ocugen's Q2 2025 results showed a slight year-over-year improvement in net loss as the company maintained momentum across multiple clinical trials. Key milestones included the start of pivotal trials for OCU410ST, continued dosing in OCU400, and progress on a Korean licensing agreement. Operating expenses declined slightly, and cash runway was extended into early 2026.

• Reported revenue of $1.37 million from a collaborative arrangement in Q2 2025.
• Net loss of $14.74 million, or $0.05 per share, improved from $15.26 million in Q2 2024.

Johnson Outdoors delivered a solid Q3 performance, highlighted by a 5% year-over-year increase in revenue and significant improvement in operating income. The Fishing segment led growth with successful new product launches, while improved gross margin and lower operating expenses supported earnings recovery.

• Revenue rose to $180.7 million, up from $172.5 million in Q3 2024.
• Net income jumped to $7.7 million from $1.6 million in the prior-year quarter.

AirSculpt's Q2 2025 results showed a 13.7% decline in revenue, but the company reduced its net loss and grew leads and consultations. Case volume dropped year-over-year, yet margin remained stable, and the business maintained its full-year outlook. The company also strengthened its balance sheet by reducing debt through a stock offering.

• Revenue declined to $44.0 million, down 13.7% year-over-year.
• Case volume fell 14.1% to 3,392, but revenue per case remained stable at $12,975.

MITT ended Q2 2025 with a slight net loss of $1.4 million but delivered $5.4 million in earnings available for distribution and raised its dividend. The company continued to enhance its residential mortgage investment platform, highlighted by the acquisition of a larger stake in Arc Home.

• Declared a $0.21 common dividend, a 5% increase from Q1 2025
• Reported a GAAP net loss of $1.4 million or $0.05 per diluted share